Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases.
We leverage our technologies and expertise to advance 7 fully owned drug discovery programs focusing on cancer resistance and escapement, a growing concern in aging populations, and chronic inflammatory diseases. We also co-develop programs with academia and pharmaceutical partners.
Our proprietary ATLAS drug discovery platform unites our technologies based on 30 years of research from renowned scientists and founders, Louis Lagardère (Sorbonne University and CNRS), Matthieu Montes (CNAM), Jean-Philip Piquemal (Sorbonne University and CNRS), Jay Ponder (Washington University in St Louis), Pengyu Ren (University of Texas at Austin).
Their multidisciplinary team of 60 experts, led by CEO Robert Marino, works from Paris, France, Boston, USA - with a team based in Chicago, USA.
Company Details
- Employees
- 69
- Founded
- -
- Address
- Paris , 75014, Fr
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- qubit-pharmaceuticals.com
- Keywords
- Computational Chemistry, Molecular Dynamics Simulation, Quantum Physics, Drug Discovery, Drug Design, Quantum Computing, Quantum Chemistry, HPC.
- HQ
- Paris
Qubit Pharmaceuticals Questions
Qubit Pharmaceuticals's website is qubit-pharmaceuticals.com
Qubit Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/qubit-pharmaceuticals
Qubit Pharmaceuticals has
69 employees.
View email and phone details for 69
employees at Qubit Pharmaceuticals.
Qubit Pharmaceuticals's industry is
Software Development
Qubit Pharmaceuticals's top competitors are
Algorithmiq,
Bioptimus,
Aqemia,
Hyvibe,
Pasqal,
Welinq,
Whitelab Genomics,
Orakl Oncology,
Biomemory,
Owkin.
Qubit Pharmaceuticals's categories are Software Development
Qubit Pharmaceuticals's founding year is 2020
